Efficient synthesis,reactions, and biological activities of new thieno and furopyrazolo[3,4-b]pyrazines and their related heterocycles

In the present investigation, a simple and straightforward methodology for the preparation of novel bifunctional thienopyrazolopyrazines 4a–d has been reported. Synthesis of thieno or furopyrazolopyrazines 5a , b , e , f was achieved by the reaction of o-amino-esters 4a , b , e , f with 2,5-dimethoxytetrahydrofuran. The latter pyrrolyl derivatives 5a , b , e , f were used as starting intermediates for the synthesis of new pyrimido, pyrido, and pyrazino heterocycles fused to the thieno or furopyrazolopyrazine moiety. Furthermore, alkaline hydrolysis of the o-amino-ester 4a followed by acidification afforded the corresponding o-amino carboxylic acid 15 , which was used as a versatile precursor for the synthesis of other heterocyclic compounds fused to the thienopyrazolopyrazine ring system, namely: pyrimidine, oxazine, oxazepine, and pyridine derivatives 16–23 . The chemical structures of the synthesized compounds were confirmed on the basis of elemental and spectral analyses (Fourier-transform infrared spectroscopy [FT-IR], ¹H nuclear magnetic resonance [NMR], and mass spectroscopy [MS] in addition to ¹³C NMR for some of them). Moreover, from the biological screening, we found that most of the tested compounds exhibited promising antifungal, antibacterial, and anti-inflammatory activities compared with the corresponding reference drugs.     

Determination of Cu,Zn, and Se in microvolumes of liquid biological samples

Cu, Zn, and Se were successfully determined in a few microliters (<100 μl) of biological samples using discrete injection atomic absorption spectrometry. Different factors were investigated in order to obtain a biological sample volume which is valid for analysis. Among them are the effect of microsampling volume variations (starting from 40 to 200 μl), nebulization efficiency, detection limits, precision, and finally the calibration and sensitivity of the proposed method. It was found that 60 μl of the biological sample was adequate for the quantitative analysis with reasonable precision. The advantages of the proposed method are not only rapidity, simplicity, sensitivity, and good precision, but also, contrary to conventional flame atomic absorption spectrometry, the capability of analyzing microvolumes of samples.     

Tissue distribution and metabolism of the putative cancer chemopreventive agent 3′,4′,5′‐trimethoxyflavonol (TMFol) in mice

3′,4′,5′‐Trimethoxyflavonol (TMFol) is a synthetic flavonol with preclinical cancer chemopreventive properties. The hypothesis was tested that, in mice, p.o. administration of TMFol results in measureable levels of the parent in target tissues. A single oral dose (240 mg/kg) was administered to mice (n = 4 per time point) with time points ranging from 5 to 1440 min. TMFol and its metabolites were identified and quantitated in all tissues by high‐performance liquid chromatography (HPLC). Plasma levels of TMFol were at the limit of quantification or below, although metabolites were identified. Peak levels of TMFol in the gastrointestinal tract and the prostate averaged 1671 ± 265 µg/g (5.3 µmol/g) and 6.0 ± 1.6 µg/g (18.4 nmol/g), and occurred 20 and 360 min post‐dose, respectively. The area under the tissue concentration–time curve (AUC) for TMFol was greater than those of the metabolites, indicating that TMFol is relatively metabolically stable. Micromolar TMFol levels are easily achieved in the prostate and gastrointestinal tract, suggesting that TMFol might exert chemopreventive efficacy at these tissue sites. Further investigations are warranted to elucidate the potential chemopreventive potency of TMFol. Copyright © 2012 John Wiley & Sons, Ltd.     

Closed 2-Form of 2D Black Holes from Geometric Prequantization Method

In this paper, we consider effective Hamiltonian of 2D dilatonic black hole adding Axion field and calculate closed 2-form by using geometric prequantization method. It yields to the Schrödinger equation which may be solved to obtain wave function. We obtained a condition on the cosmological constant to obtain appropriate Hamilton equation of motions.     

Discovery of New Pyrazolopyridine,Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design,Synthesis, Docking Studies,and Anti-Proliferative Activity

New pyridine, pyrazoloyridine, and furopyridine derivatives substituted with naphthyl and thienyl moieties were designed and synthesized starting from 6-(naphthalen-2-yl)-2-oxo-4-(thiophen-2-yl)-1,2-dihydropyridine-3-carbonitrile (1). The chloro, methoxy, cholroacetoxy, imidazolyl, azide, and arylamino derivatives were prepared to obtain the pyridine-⁻C² functionalized derivatives. The derived pyrazolpyridine-N-glycosides were synthesized via heterocyclization of the C²-thioxopyridine derivative followed by glycosylation using glucose and galactose. The furopyridine derivative 14 and the tricyclic pyrido[3′,2′:4,5]furo[3,2-d]pyrimidine 15 were prepared via heterocyclization of the ester derivative followed by a reaction with formamide. The newly synthesized compounds were evaluated for their ability to in vitro inhibit the CDK2 enzyme. In addition, the cytotoxicity of the compounds was tested against four different human cancer cell lines (HCT-116, MCF-7, HepG2, and A549). The CDK2/cyclin A2 enzyme inhibitory results revealed that pyridone 1, 2-chloro-6-(naphthalen-2-yl)-4-(thiophen-2-yl)nicotinonitrile (4), 6-(naphthalen-2-yl)-4-(thiophen-2-yl)-1H-pyrazolo[3,4-b]pyridin-3-amine (8), S-(3-cyano-6-(naphthaen-2-yl)-4-(thiophen-2-yl)pyridin-2-yl) 2-chloroethanethioate (11), and ethyl 3-amino-6-(naphthalen-2-yl)-4-(thiophen-2-yl)furo[2,3-b]pyridine-2-carboxylate (14) are among the most active inhibitors with IC₅₀ values of 0.57, 0.24, 0.65, 0.50, and 0.93 µM, respectively, compared to roscovitine (IC₅₀ 0.394 μM). Most compounds showed significant inhibition on different human cancer cell lines (HCT-116, MCF-7, HepG2, and A549) with IC₅₀ ranges of 31.3–49.0, 19.3–55.5, 22.7–44.8, and 36.8–70.7 μM, respectively compared to doxorubicin (IC₅₀ 40.0, 64.8, 24.7 and 58.1 µM, respectively). Furthermore, a molecular docking study suggests that most of the target compounds have a similar binding mode as a reference compound in the active site of the CDK2 enzyme. The structural requirements controlling the CDK2 inhibitory activity were determined through the generation of a statistically significant 2D-QSAR model.     

Nanostructure-based electrochemical sensor for determination of glutathione in hemolysed erythrocytes and urine

A sensitive and selective electrochemical method was developed for the determination of glutathione (GSH) in hemolysed erythrocyte using vinylferocene modified carbon nanotubes paste electrode (VFMCNTPE). The results indicate that the electrode is efficient in terms of its electrocatalytic activity for the oxidation of GSH, leading to a reduced overpotential by more than 470 mV. Also, the values of catalytic rate constant (k), and diffusion coefficient (D) for GSH were calculated. The electrocatalytic oxidation peak current of GSH showed two linear dynamic ranges with a detection limit of 0.09 μM GSH. The linear calibration ranges were obtained between 0.2–4.0 and 4.0–250.0 μM GSH using square wave voltammetry (SWV) method. The proposed method was also examined as a selective, simple and precise electrochemical sensor for the determination of GSH in real samples such as urine and hemolysed erythrocyte.     

A Cheap and Efficient Methodology for the Solvent‐Free,One‐pot and Multi‐component Synthesis of 3,4‐Dihydropyrimidin‐2(1H)‐ones Catalyzed by Mesoporous NH4H2PO4/MCM‐48 and Comparison of Its Catalytic Efficacy with NH4H2PO4/MCM‐41

The catalytic efficiency of ammonium dihydrogenphosphate was evaluated in the two heterogeneous forms of NH₄H₂PO₄/MCM‐48 and NH₄H₂PO₄/MCM‐41, as mesoporous catalysts, in the solvent free synthesis of 3,4‐dihydropyrimidin‐2(1H)‐ones through one‐pot three‐component condensation of ethyl acetoacetate, an aryl aldehyde and urea. Different reaction parameters including catalytic efficacy, solvent effect, and urea concentration are considered.     

An in silico approach to design peptide mimetics based on docking and molecular dynamics simulation of EGFR–matuzumab complex

Epidermal growth factor receptor (EGFR) plays an essential role in anticancer therapy. Matuzumab is an antibody for the treatment of colorectal, lung and stomach cancer. Matuzumab binds efficiently to EGFR and blocks its phosphorylation. The recent clinical successes have established application of peptides for cancer treatment. The present contribution introduces an in silico approach to design peptides based on molecular dynamics simulation (MDs) of the matuzumab-EGFR complex in water environment. Moreover, principal component analysis has been used to select multiple conformations of the complex in MDs for designing the peptides. The paratope and epitope in each conformation of the complex were determined, and the alanine scanning was used to identify the hot spots of EGFR conformers. The conformations of the peptides were optimized using PEP-FOLD server and MDs. The selected conformations were analyzed in a docking study to realize the binding site of the EGFR. Finally, pharmokinetics properties of the peptides were calculated. The designed oligopeptides were EWRSYYYWH, YYYWHNEWN, YYYWHNEWS and HNHSRNYGS with a higher affinity to the EGFR relative to the previously reported peptides. The newly designed peptides were investigated for their in vivo toxicities on rats, and all of them were non-toxic.